In line with the differences in interaction with the IgG subclasses, FcγR polymorphisms were found to correlate with IgG-dependent diseases, such as in allo- and autoimmunity [39,40,41], and with outcome of treatment in therapeutic antibody regimens that trigger FcγR for its therapeutic effect [21]. The gene discussed is FCGR2A; the disease is Autoimmunity.